Clinical Trials Browser

NCT04876651 2026-02-20

The Present Study Aims to Compare Patients Who Receive the Investigational Product (177Lu-DOTA-rosopatamab) Plus Standard of Care, in Comparison to Standard of Care Only

Phase 3 Terminated

16 enrolled

Genitourinary

Prostatic Neoplasms

NCT04149574 2025-09-16

CheckMate 7G8

Phase 3 Terminated

13 enrolled 11 charts

Genitourinary

Urinary Bladder Neoplasms

NCT04588246 2025-06-06

Comparing Whole Brain Radiotherapy Using a Technique That Avoids the Hippocampus to Stereotactic Radiosurgery in Patients With Cancer That Has Spread to the Brain and Come Back in Other Areas of the Brain After Earlier Stereotactic Radiosurgery

Phase 3 Terminated

19 enrolled 19 charts

BreastCNSDermatologicGastrointestinalGenitourinaryThoracic

Brain Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Gastrointestinal Neoplasms, Lung Neoplasms, Melanoma, Neoplasm Metastasis, Small Cell Lung Carcinoma

NCT04261777 2025-06-03

Ferumoxtran-10-enhanced MRI in Prostate Cancer Patients

Phase 3 Terminated

172 enrolled

Genitourinary

Neoplasm Metastasis, Prostatic Neoplasms

NCT03862170 2025-02-12

BRP30

Phase 3 Terminated

158 enrolled

Genitourinary

Prostatic Neoplasms

NCT03031821 2024-10-04

PRIME

Phase 3 Terminated

168 enrolled

Genitourinary

Prostatic Neoplasms, Metabolic Syndrome

NCT03056638 2024-08-28

Trial of ADT and SBRT Versus SBRT for Intermediate Prostate Cancer

Phase 3 Terminated

56 enrolled 8 charts

Genitourinary

Prostatic Neoplasms

NCT03850795 2024-08-19

HC-1119 Versus Enzalutamide in Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Phase 3 Terminated

104 enrolled

Genitourinary

Prostate Cancer Metastatic

NCT04907227 2024-07-12

KEYNOTE-921

Phase 3 Terminated

81 enrolled 19 charts

Genitourinary

Parkinson Disease 4, Autosomal Dominant Lewy Body, Prostatic Neoplasms

NCT04688931 2024-06-06

ATLAS

Phase 3 Terminated

282 enrolled 29 charts

Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

NCT04197986 2024-03-13

PROOF302

Phase 3 Terminated

39 enrolled 31 charts

Genitourinary

Upper Tract Urothelial Carcinomas

NCT04844749 2024-02-05

VERACITY

Phase 3 Terminated

105 enrolled

Genitourinary

Prostatic Neoplasms, Castration-Resistant

NCT04409288 2024-01-05

Patient Preference of Apalutamide Versus Enzalutamide in Patients With Recurrent or Metastatic Hormone-Sensitive Prostate Cancer

Phase 3 Terminated

74 enrolled

Genitourinary

Prostatic Neoplasms, Patient Preference

NCT00352079 2023-08-04

BCG With or Without Gefitinib in Treating Patients With High-Risk Bladder Cancer

Phase 3 Terminated

41 enrolled

Genitourinary

Urinary Bladder Neoplasms

NCT00651326 2023-08-04

DART

Phase 3 Terminated

48 enrolled

Genitourinary

Prostatic Neoplasms

NCT03024996 2023-08-03

IMmotion010

Phase 3 Terminated

778 enrolled 19 charts

Genitourinary

Carcinoma, Renal Cell

NCT02450331 2023-06-18

IMvigor010

Phase 3 Terminated

809 enrolled 19 charts

Genitourinary

Carcinoma, Transitional Cell

NCT03535675 2023-05-22

Muscadine Plus (MPX) In Men With Prostate Cancer

Phase 3 Terminated

59 enrolled 9 charts

Genitourinary

Adenocarcinoma of the Prostate

NCT03729245 2023-04-11

A Study of Bempegaldesleukin (NKTR-214: BEMPEG) in Combination With Nivolumab Compared With the Investigator's Choice of a Tyrosine Kinase Inhibitor (TKI) Therapy (Either Sunitinib or Cabozantinib Monotherapy) for Advanced Metastatic Renal Cell Carcinoma (RCC)

Phase 3 Terminated

623 enrolled 14 charts

Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms

NCT02438007 2023-03-15

ARMOR3-SV

Phase 3 Terminated

953 enrolled

Genitourinary

Prostatic Neoplasms

NCT03921996 2023-03-09

Extended Pelvic Lymph Node Dissection vs. no Pelvic Lymph Node Dissection at Radical Prostatectomy for intermediate-and High-risk Prostate Cancer

Phase 3 Terminated

57 enrolled

Genitourinary

Prostatic Neoplasms

NCT05744115 2023-02-24

Ga68-PSMA-11

Phase 3 Terminated

38 enrolled

Genitourinary

Prostatic Neoplasms

NCT02745587 2022-12-28

PROPER

Phase 3 Terminated

69 enrolled

Genitourinary

Prostatic Neoplasms

NCT02663908 2022-06-29

PRONOUNCE

Phase 3 Terminated

545 enrolled 36 charts

Genitourinary

Prostatic Neoplasms

NCT02563561 2021-10-27

A Study of Intravesical Apaziquone as a Surgical Adjuvant in Participant Undergoing Transurethral Resection Bladder Tumor (TURBT)

Phase 3 Terminated

62 enrolled 10 charts

Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT03408652 2021-10-22

MOSCAR

Phase 3 Terminated

1 enrolled

Genitourinary

Carcinoma, Renal Cell

NCT00354432 2021-09-28

Soy Protein/Effexor Hormone Therapy for Prostate Cancer

Phase 3 Terminated

120 enrolled 11 charts

Genitourinary

Prostatic Neoplasms, Hot Flashes

NCT03224182 2021-09-28

A Study of Intravesical Qapzola (Apaziquone) as a Surgical Adjuvant in Participants Undergoing Transurethral Resection of Bladder Tumor (TURBT)

Phase 3 Terminated

118 enrolled 10 charts

Genitourinary

Urinary Bladder Neoplasms

NCT02057666 2021-04-23

TasQ003

Phase 3 Terminated

146 enrolled 13 charts

Genitourinary

Neoplasm Metastasis, Prostatic Neoplasms, Prostatic Neoplasms, Castration-Resistant

NCT03327662 2021-01-06

CTC-STOP

Phase 3 Terminated

12 enrolled

Genitourinary

Adenocarcinoma of the Prostate

NCT00058188 2020-12-08

Zolendronate for the Prevention of Bone Loss in Men w/ Prostate CA on Long-Term Androgen Deprivation

Phase 3 Terminated

53 enrolled

Genitourinary

Osteoporosis, Prostatic Neoplasms

NCT01987596 2020-10-29

Study of Fixed vs. Flexible Filgrastim to Accelerate Bone Marrow Recovery After Chemotherapy in Children With Cancer

Phase 3 Terminated

23 enrolled 9 charts

CNSGenitourinaryOther solid neoplasmSarcoma

Medulloblastoma, Wilms Tumor, Neuroblastoma, Recurrence, Retinoblastoma, Osteosarcoma, Choroid Plexus Neoplasms

NCT00003645 2020-04-28

Randomized Trial of Adjuvant Hormonal Therapy in Surgically Treated Prostate Cancer Patients at High Risk for Recurrence

Phase 3 Terminated

64 enrolled 12 charts

Genitourinary

Prostatic Neoplasms

NCT03335059 2020-04-15

RITE-USA

Phase 3 Terminated

5 enrolled

Genitourinary

Urinary Bladder Neoplasms, Disease

NCT00415246 2019-11-22

Study to Evaluate a Subcutaneous Four Months Sustained-release Formulation of Triptorelin in Patients With Prostate Cancer

Phase 3 Terminated

100 enrolled

Genitourinary

Prostatic Neoplasms

NCT01313273 2019-11-22

POSEIDON

Phase 3 Terminated

3 enrolled 4 charts

Genitourinary

Prostatic Neoplasms

NCT01599754 2019-09-20

ATLAS

Phase 3 Terminated

724 enrolled 17 charts

Genitourinary

Carcinoma, Renal Cell

NCT02982395 2019-08-30

Study to Evaluate the Efficacy and Safety Of Intravesical Nanoxel®M In BCG Refractory NMIBC

Phase 3 Terminated

36 enrolled

Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Carcinoma, Transitional Cell

NCT01198158 2019-03-06

Everolimus With or Without Bevacizumab in Treating Patients With Advanced Kidney Cancer That Progressed After First-Line Therapy

Phase 3 Terminated

77 enrolled 11 charts

Genitourinary

Carcinoma, Renal Cell

NCT00544076 2019-01-02

ED Recovery in Men Age </=65 Treated With Bilateral Nerve Sparing Robotic Assisted Prostatectomy for Prostate Cancer

Phase 3 Terminated

110 enrolled 9 charts

Genitourinary

Erectile Dysfunction, Prostatic Neoplasms

NCT00540969 2018-11-21

Cryoablation or External-Beam Radiation Therapy in Treating Patients With Painful Bone Metastases

Phase 3 Terminated

3 enrolled 1 chart

DermatologicGenitourinary

Carcinoma, Renal Cell, Kidney Neoplasms, Melanoma, Neoplasm Metastasis, Pain

NCT01522443 2018-05-23

COMET-2

Phase 3 Terminated

119 enrolled 21 charts

Genitourinary

Pain, Prostatic Neoplasms

NCT01469221 2017-12-15

Efficacy and Safety Study of Apaziquone vs. Placebo in Patients With Non-Muscle Invasive Bladder Cancer (NMIBC)

Phase 3 Terminated

47 enrolled 11 charts

Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT01310803 2017-10-05

Multi-center Study to Evaluate the Efficacy and Safety of Maintenance Therapy With Valrubicin Versus no Maintenance, in Subjects Treated With Valrubicin Induction for Carcinoma in Situ (CIS) of the Bladder

Phase 3 Terminated

1 enrolled 5 charts

Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Diseases, Urinary Bladder Neoplasms, Carcinoma in Situ, Carcinoma, Transitional Cell, Neoplasms, Neoplasms by Site, Urogenital Neoplasms, Urologic Diseases, Urologic Neoplasms

NCT00005047 2017-06-08

4B951, Combination Chemotherapy in Treating Patients With Bladder Cancer

Phase 3 Terminated

521 enrolled 18 charts

Genitourinary

Urinary Bladder Neoplasms

NCT00324324 2017-05-09

Moxifloxacin in Preventing Bacterial Infections in Patients Who Have Undergone Donor Stem Cell Transplant

Phase 3 Terminated

240 enrolled

BreastCNSDermatologicGenitourinaryGynecologicLymphoidMyeloidOther hematologic neoplasmPlasma cell

Testicular Germ Cell Tumor, Pdgfra-Associated Chronic Eosinophilic Leukemia, Congenital Abnormalities, Carcinoma, Ovarian Epithelial, Blast Crisis, Breast Neoplasms, Burkitt Lymphoma, Hodgkin Disease, Infections, Leukemia, Leukemia, Hairy Cell, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Multiple Myeloma, Mycosis Fungoides, Myelodysplastic Syndromes, Myeloproliferative Disorders, Neuroblastoma, Ovarian Neoplasms, Sezary Syndrome, Testicular Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Neutrophilic, Chronic, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Gestational Trophoblastic Disease, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative, Primary Myelofibrosis

NCT01410565 2016-12-13